Effects of EGTA and cytochalasin-B during freezing and vitrification of immature and mature bovine and rhesus monkey (M. mulatta) oocytes. by YOUNIS, A. I. et al.
Theriogenology 361 
EFFECTS OF EGTA AND CYTOCHALASIN-B DURING FREEZING AND VITRIFICATION 
OF IMMATURE AND MATURE BOVINE AND RHESUS MONKEY (M. mulafta) OOCYTES 
A.I.Younis’, L.Keskintepe2, A.A.Simplicio2* K. Gould’, and B.G.Brackett2 
‘Division of Molecular Medicine, Yerkes Primate Research Center, Emory University, Atlanta GA 
30329, 2Department of Physiology & Pharmacology, College of Veterinary Medicine, 
UGA, Athens, GA 30602, USA 
Cryopreservation procedures have been shown to be extremely disruptive to the plasma 
membrane and intracellular organization of mammalian oocyte. Cytochalasin-B (Cyt-B) or EGTA 
may stabilize oocyte cytoskeletal elements prior to Cryopreservation and make the plasma 
membrane less rigid and mote elastic to avoid injury during the osmotic stresses of freezing. 
Experiments were conducted to assess the morphological viability and developmental potential of 
bovine and rhesus monkey oocytes after exposure to Cyt-B or EGTA prior to freezing and 
vitrification. In the bovine experiments: The methods of oocyte isolation, in vitro maturation 
(IVM), in vitro fertilization (IVF) , and embryonic development (IVC) were as described elsewhere 
(Biol Reprod. 55:333-339, 1996). All data were analyzed by ANOVA and Chi-square using 
“StatMost” for Windows. In an initial experiment, a group of immature (GV) oocytes and oocytes 
after IVM (ova) were randomly selected and pretreated for 5 min with EGTA (O.lM) or Cyt-B 
(lmg/ml) without cryoprotectant (CPA), and another group were equilibrated for 15 min with the 
CPA (1.5 M ethylene glycol mixed with 0.5 M glycerol in PBS) after pretreatment with EGTA or 
Cyt-B. All oocytes were diluted and/or washed and immediately used for IVM and/or IVF and 
IVC. No significant differences in cleavage (C) development and blastocyst (B) hatching among 
treatments in the GV oocytes group. Percentages of early C, motula (M), B, and expanded B 
(EB) development ranged 72-82% , 53-650/o, 40-478 and 25-350/o respectively. Ova treated 
with EGTA without CPA produced significantly (Pc.05) higher C (31/41, 75%), M (48.8%). B 
(40%) and EB (24.4%) than with Cyt-B. In the slow freezing experiment, a total of 105 GV 
oocytes and 155 ova were exposed to (a) zero (b EGTA , or (c) Cyt-B before equilibration with 
CPA + 0.5 sucrose in PBS plus 15% Fetal bovine serum (PBS/FBS). Gametes were loaded into 
sterile cryovials, cooled at 2”C/min to -7”C, seeded, cooled at 0.3‘C/min to -32°C then plunged 
in LN,. They were thawed in air (10 set), then warm water (35”C), and diluted out of CPA in 3 
steps (1, 0.5, 0.2 M sucrose). Three replicated showed that although many of the frozen-thawed 
oocytes/ova survived as judged by morphology (range 70-80%), their developmental potential was 
severely retarded. C ranged between 0% to 14.3%. In the vitrification experiment, a total of 135 
GV oocytes and 90 ova were grouped as above and vitrified in straws containing a mixture of 
3.25M glycerol and 4.SM ethylene glycol plus 0.5 sucrose in PBS/FBS. Here, higher (Pc.05) 
morphological survival rates (98%) followed pretreatment with EGTA. However, the 
developmental potential was very low among all groups ranging between 0% to 17.7%. In the 
monkey experiments: The methods of oocyte isolation, IVM and IVF was as described ( 
Theriogenology 43:362, 1995). A total of 72 GV oocytes and 42 ova were subjected to slow rate 
freezing and vitrification in groups as described for cow oocytes above. Pretreatment of both GV 
oocytes or ova with EGTA or Cyt-B prior to freezing or vitrification resulted in 77.6% 
morphological survival which was significantly (Pc.01) higher than for the control (50%). No 
differences in fertilization and development were detected among treatment. Percentages of C to 
4-cell stage ranged from 5067%. Results suggest prefreeze treatment with EGTA and/or Cyt-B 
may be useful in enhancement of oocyte/ovum cryopreservation. 
